CDCA8 and cancer: Thus, these results indicate that CDCA8 promotes cell growth and cancer metastasis and leads to poor survival in liver cancer patients through the above signaling pathways, and that CDCA8 could serve as a new therapeutic target and prognostic marker in liver cancer.